A 46-year-old man with a past history of retroperitoneal fibrosis was admitted with an enlarged, hard right testis. The paratesticular lesion showed heterogeneous hypoechogenicity on ultrasonography, low signal intensity on T1- and T2-weighted magnetic resonance imaging (MRI), and lack of diffusion restriction on diffusion-weighted MRI. Following steroid treatment, the paratesticular mass was decreased in size on follow-up computed tomography. The radiologic and clinical features are recognized as a manifestation of immunoglobulin G4-related sclerosing disease involving the paratesticular region and retroperitoneum.

Keywords:
Immunoglobulin G4, Pseudotumor, Scrotum, Magnetic resonance imaging
1.
Dieckmann KP, Struss WJ, Frey U, Nahler-Wildenhain M: Paratesticular fibrous pseudotumor in young males presenting with histological features of IgG4-related disease: two case reports. J Med Case Rep 2013;7:225.
2.
Bösmüller H, von Weyhern CH, Adam P, Alibegovic V, Mikuz G, Fend F: Paratesticular fibrous pseudotumor - an IgG4-related disorder? Virchows Arch 2011;458:109-113.
3.
Hart PA, Moyer AM, Yi ES, Hogan MC, Pearson RK, Chari ST: IgG4-related paratesticular pseudotumor in a patient with autoimmune pancreatitis and retroperitoneal fibrosis: an extrapancreatic manifestation of IgG4-related disease. Hum Pathol 2012;43:2084-2087.
4.
Vlachou PA, Khalili K, Jang HJ, Fischer S, Hirschfield GM, Kim TK: IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics 2011;31:1379-1402.
5.
Okazaki K, Uchida K, Koyabu M, Miyoshi H, Takaoka M: Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011;46:277-288.
6.
Cassidy FH, Ishioka KM, McMahon CJ, Chu P, Sakamoto K, Lee KS, Aganovic L: MR imaging of scrotal tumors and pseudotumors. Radiographics 2010;30:665-683.
7.
Ghazale A, Chari ST: Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007;56:1650-1652.
8.
Horger M, Lamprecht HG, Bares R, Spira D, Schmalzing M, Claussen CD, Adam P: Systemic IgG4-related sclerosing disease: spectrum of imaging findings and differential diagnosis. AJR Am J Roentgenol 2012;199:W276-W282.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.